| Extrapulmonary Small Cell Neuroendocrine Carcinoma studied in …STUDIED_INderived30 of 30show fewer |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 30 trials mapped (14 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04723095recruiting Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 30 trials mapped (14 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04592237Phase 2 · active not recruiting Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 30 trials mapped (14 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896503Phase 2 · active not recruiting Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs · condition mapped ONTOLOGY_EXACT · 30 trials mapped (14 active) | — | — | Extrapulmonary Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04471974Phase 2 · active not recruiting ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 30 trials mapped (14 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691465Phase 2 · recruiting Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells · condition mapped CURATED_BROADER · 30 trials mapped (14 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04010357Phase 2 · completed Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Extrapulmonary Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 30 trials mapped (14 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07501650Phase 1 · recruiting Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Head and Neck Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07276360Phase 2 · recruiting Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04754425Phase 2 · terminated Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 30 trials mapped (14 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03582475Phase 1 · active not recruiting Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate · condition mapped ONTOLOGY_EXACT · 30 trials mapped (14 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05173246Phase 2 · recruiting JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Esophageal Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06094842Phase 1 · withdrawn Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (14 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06478264Phase 2 · not yet recruiting A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Esophageal Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06464068Phase 2 · recruiting AGNOSTIC THERAPY IN A PHASE II SINGLE-ARM STUDY IN FIRST-LINE TREATMENT OF DURVALUMAB IN ASSOCIATION WITH CARBOPLATIN OR CISPLATIN AND ETOPOSIDE IN PATIENTS AFFECTED BY EXTENSIVE STAGE - EXTRAPULMONARY SMALL CELL CARCINOMA · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Extrapulmonary Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02164461Phase 1 · completed Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03649841Phase 2 · terminated Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (14 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01505868Phase 1/Phase 2 · completed Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04721184unknown Impact of Low Muscle Mass in HNC Treated With Immunotherapy · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Head and Neck Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01266447Phase 2 · completed Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416455Phase 1/Phase 2 · completed Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03811379Phase 2 · unknown Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Esophageal Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00309959Phase 2 · completed ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00460356completed Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00897442completed Collecting Tumor Samples From Patients With Gynecological Tumors · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217633Phase 2 · completed Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104910Phase 1 · completed Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068549Phase 1 · completed Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer · condition mapped ALIAS · 30 trials mapped (14 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |